These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9295972)
1. [Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene]. Merle P; Levy R; Vitvitski L; Chevallier M; Buendia MA; Trepo C Gastroenterol Clin Biol; 1997; 21(6-7):459-65. PubMed ID: 9295972 [TBL] [Abstract][Full Text] [Related]
2. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981 [TBL] [Abstract][Full Text] [Related]
3. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II. Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591 [TBL] [Abstract][Full Text] [Related]
4. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Etiemble J; Degott C; Renard CA; Fourel G; Shamoon B; Vitvitski-Trépo L; Hsu TY; Tiollais P; Babinet C; Buendia MA Oncogene; 1994 Mar; 9(3):727-37. PubMed ID: 8108115 [TBL] [Abstract][Full Text] [Related]
6. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836 [TBL] [Abstract][Full Text] [Related]
7. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693 [TBL] [Abstract][Full Text] [Related]
8. Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice. Merle P; Chevallier M; Levy R; Maisonnas M; Terradillos O; Ahmed SNS ; Trépo C; Buendia MA; Vitvitski-Trépo L J Hepatol; 2001 Apr; 34(4):562-9. PubMed ID: 11394656 [TBL] [Abstract][Full Text] [Related]
9. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice]. Liu P; Zhao Z; Dominique B Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423 [TBL] [Abstract][Full Text] [Related]
10. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain. De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741 [TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides. Moriya K; Matsukura M; Kurokawa K; Koike K Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134 [TBL] [Abstract][Full Text] [Related]
12. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats. Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. Calvisi DF; Thorgeirsson SS Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070 [TBL] [Abstract][Full Text] [Related]
14. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Yang D; Alt E; Rogler CE Cancer Res; 1993 May; 53(9):2020-7. PubMed ID: 8481904 [TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484 [TBL] [Abstract][Full Text] [Related]
16. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Morrey JD; Korba BE; Sidwell RW Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056 [TBL] [Abstract][Full Text] [Related]
17. [Hepatitis B virus and hepatocellular carcinoma]. Tiollais P; Dejean A; Buendia MA Bull Acad Natl Med; 1991 Feb; 175(2):263-71; discussion 271-2. PubMed ID: 1650625 [TBL] [Abstract][Full Text] [Related]
18. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Calvisi DF; Factor VM; Loi R; Thorgeirsson SS Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770 [TBL] [Abstract][Full Text] [Related]
19. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes. Sargent LM; Sanderson ND; Thorgeirsson SS Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862 [TBL] [Abstract][Full Text] [Related]
20. Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma. Bruni R; D'Ugo E; Giuseppetti R; Argentini C; Rapicetta M Virology; 1999 May; 257(2):483-90. PubMed ID: 10329558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]